Summary
Intermediate and Middle Bronze Age tombs with weapons (mainly daggers) in the southern Levant were often interpreted as ‘warrior graves’. Taking into consideration new data from Rishon Le‐Zion (Israel), recent work on early warfare and warriors, and a study of so‐called ‘warrior graves’ in Mesopotamia (Rehm 2003), we suggest that most of these graves are not graves of elite warriors, but typical male burials. We also discuss the assumed ‘burial kit’ and the decline in numbers of weapons per burial, which is in our view related to the shift from individual burials (in the Intermediate Bronze and Middle Bronze IIA periods) to multiple shaft burials (in the Middle Bronze IIB period).
The Middle Bronze Age II is a period during which there exists a contemporaneous usage of arsenic copper and tin bronze for metal weaponry production. In order to learn more about the alloys used in this period, the blades and rivets from 65 daggers of two significantly different types, which were discovered at the Rishon LeZion (RL) cemetery, Israel, were tested by the non-destructive method of X-ray fluorescence (XRF). The results reveal new knowledge of the alloys selected for dagger and rivet production, both of which represent fine examples of the Middle Bronze Age II Southern Levant in metal industry.
A rich assemblage of Middle Bronze Age II daggers from the Rishon le-Zion excavations in Israel was studied. These daggers were found to be made of tin-bronze, arsenical copper or copper with tin and arsenic. Relations between type, shape and composition are established, showing that greater control of composition and shape are directly related to the production of more stylish decorated objects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.